Sökning: id:"swepub:oai:gup.ub.gu.se/327280" >
Safety and effectiv...
Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015-2022): 2022 interim analysis
-
Mercuri, E. (författare)
-
Osorio, A. N. (författare)
-
Muntoni, F. (författare)
-
visa fler...
-
Buccella, F. (författare)
-
Desguerre, I. (författare)
-
Kirschner, J. (författare)
-
- Tulinius, Mar, 1953 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics
-
de Resende, M. B. D. (författare)
-
Morgenroth, L. P. (författare)
-
Gordish-Dressman, H. (författare)
-
Johnson, S. (författare)
-
Kristensen, A. (författare)
-
Werner, C. (författare)
-
Trifillis, P. (författare)
-
Henricson, E. K. (författare)
-
McDonald, C. M. (författare)
-
Stride Investigator, Stride Investigator (författare)
-
Cinrg Dnhs Investigator, Cinrg Dnhs Investigator (författare)
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: Journal of Neurology. - 0340-5354. ; 270, s. 3896-3913
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- ObjectiveStrategic Targeting of Registries and International Database of Excellence (STRIDE) is an ongoing, international, multicenter registry of real-world ataluren use in individuals with nonsense mutation Duchenne muscular dystrophy (nmDMD) in clinical practice. This updated interim report (data cut-off: January 31, 2022), describes STRIDE patient characteristics and ataluren safety data, as well as the effectiveness of ataluren plus standard of care (SoC) in STRIDE versus SoC alone in the Cooperative International Neuromuscular Research Group (CINRG) Duchenne Natural History Study (DNHS).MethodsPatients are followed up from enrollment for at least 5 years or until study withdrawal. Propensity score matching was performed to identify STRIDE and CINRG DNHS patients who were comparable in established predictors of disease progression.ResultsAs of January 31, 2022, 307 patients were enrolled from 14 countries. Mean (standard deviation [SD]) ages at first symptoms and at genetic diagnosis were 2.9 (1.7) years and 4.5 (3.7) years, respectively. Mean (SD) duration of ataluren exposure was 1671 (56.8) days. Ataluren had a favorable safety profile; most treatment-emergent adverse events were mild or moderate and unrelated to ataluren. Kaplan-Meier analyses demonstrated that ataluren plus SoC significantly delayed age at loss of ambulation by 4 years (p < 0.0001) and age at decline to %-predicted forced vital capacity of < 60% and < 50% by 1.8 years (p = 0.0021) and 2.3 years (p = 0.0207), respectively, compared with SoC alone.ConclusionLong-term, real-world treatment with ataluren plus SoC delays several disease progression milestones in individuals with nmDMD. NCT02369731; registration date: February 24, 2015.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Nyckelord
- Ataluren
- Effectiveness
- Nonsense mutation Duchenne muscular dystrophy
- Safety
- STRIDE Registry
- muscular-dystrophy
- multicenter
- diagnosis
- Neurosciences & Neurology
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Mercuri, E.
-
Osorio, A. N.
-
Muntoni, F.
-
Buccella, F.
-
Desguerre, I.
-
Kirschner, J.
-
visa fler...
-
Tulinius, Mar, 1 ...
-
de Resende, M. B ...
-
Morgenroth, L. P ...
-
Gordish-Dressman ...
-
Johnson, S.
-
Kristensen, A.
-
Werner, C.
-
Trifillis, P.
-
Henricson, E. K.
-
McDonald, C. M.
-
Stride Investiga ...
-
Cinrg Dnhs Inves ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Neurovetenskaper
- Artiklar i publikationen
-
Journal of Neuro ...
- Av lärosätet
-
Göteborgs universitet